NUTRITIONAL HIGH AND NEUTRISCI INTERNATIONAL TO LAUNCH CANNABIS INFUSED TABLETS JULY 11TH

VANCOUVER, British Columbia, July 10, 2018 (GLOBE NEWSWIRE) — NeutriSci International Inc. (“NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer [...]

NEUTRISCI PROVIDES UPDATE ON PATENT PENDING TECHNOLOGY

VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (“NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer [...]

NEUTRISCI AND NUTRITIONAL HIGH ENTER INTO AGREEMENT TO DEVELOP, MANUFACTURE & DISTRIBUTE CANNABIS INFUSED PRODUCTS

Vancouver, British Columbia – May 30, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and [...]

NEUTRISCI ANNOUNCES PARTNERSHIP WITH ROGERS CUP PRESENTED BY NATIONAL BANK

Vancouver, British Columbia – April 19, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI TO COMPLETE SHARE SETTLEMENT

Vancouver, British Columbia – March 27, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI FILES PATENT APPLICATION

Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT

Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]

NEUTRISCI NAMED TO THE 2018 TSX VENTURE 50®

  VANCOUVER, B.C. – Feb. 22, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) [...]

NEUTRISCI ANNOUNCES MAJOR SPONSORSHIP WITH TENNIS STAR GENIE BOUCHARD

Vancouver, British Columbia – January 11, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI ANNOUNCES A MAJOR R&D MOU WITH SCIENTUS PHARMA TO DEVELOP A MEDICAL CANNABINOID RETAIL PRODUCT

Vancouver, British Columbia – January 8, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and [...]